Scilex Holding (SCLX) Cash & Equivalents (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Cash & Equivalents of $144.9 million for Q1 2026, up 2397.81% year-over-year from $5.8 million in Q1 2025, and up 2823.77% on a QoQ basis from $5.0 million in Q4 2025.

Scilex Holding (SCLX) Cash & Equivalents (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Cash & Equivalents for 7 consecutive years, with $144.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 2397.81% year-over-year to $144.9 million; the TTM figure through Mar 2026 stood at $144.9 million (up 2397.81% YoY), while the FY2025 annual figure was $5.0 million, up 51.44% from the prior year.
  • Cash & Equivalents came in at $144.9 million for Q1 2026 at Scilex Holding, up from $5.0 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $144.9 million in Q1 2026, with the low at $34961.0 in Q3 2022.
  • Average Cash & Equivalents over 5 years is $13.0 million, with a median of $3.3 million recorded in 2024.
  • Across the five-year window, Cash & Equivalents soared 9613.84% in 2023 and tumbled 96.15% in 2024, its largest moves.
  • Year by year, Cash & Equivalents stood at $2.2 million in 2022, then surged by 79.53% to $3.9 million in 2023, then retreated by 16.55% to $3.3 million in 2024, then soared by 51.44% to $5.0 million in 2025, then soared by 2823.77% to $144.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $144.9 million, $5.0 million, and $900000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.28 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 21.69 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 9.39 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 7.56 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 5.33 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 12.04 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 7.63 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 1.70 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 144.87 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 144.87 Mn
Dec 31, 2025 4.96 Mn
Sep 30, 2025 900,000.00
Jun 30, 2025 4.10 Mn
Mar 31, 2025 5.80 Mn
Dec 31, 2024 3.27 Mn
Sep 30, 2024 77,000.00
Jun 30, 2024 6.89 Mn
Mar 31, 2024 1.82 Mn
Dec 31, 2023 3.92 Mn
Sep 30, 2023 2.00 Mn
Jun 30, 2023 34.12 Mn
Mar 31, 2023 5.10 Mn
Dec 31, 2022 2.18 Mn
Sep 30, 2022 34,961.00
Jun 30, 2022 351,272.00
Mar 31, 2022 127,440.00
Dec 31, 2021 4.34 Mn
Sep 30, 2021 115,642.00
Jun 30, 2021 257,621.00